BSE Shares Jump 17% as NSE Defers Monday Expiry Plans Amid SEBI's Consultation
Sandip Raj Gupta
28/Mar/2025

-
BSE shares surged 17% after NSE deferred shifting expiry days following SEBI's consultation.
-
SEBI proposed limiting equity derivatives expiry to Tuesday or Thursday for market stability.
-
Jefferies maintained a 'hold' rating on BSE shares with a target price of ₹5,250.
BSE Shares Rally as NSE Holds Back Expiry Shift Plans
The shares of Asia’s oldest stock exchange, BSE, surged 17% on March 28 after its competitor, the National Stock Exchange (NSE), decided to defer its plan to shift derivatives expiry days to Monday. The decision followed the Securities and Exchange Board of India’s (SEBI) consultation paper, which suggested that all equity derivatives expiries be limited to either Tuesday or Thursday to maintain optimal spacing.
At 10:50 AM, BSE shares were trading at ₹5,494 per share, significantly up from the previous session’s close.
SEBI’s Directive and Market Impact
According to sources, SEBI has advised exchanges to maintain the status quo on expiry dates for now. The consultation paper also proposed that any changes in contract expiry or settlement days must be pre-approved by SEBI.
This move comes after NSE’s announcement to shift expiry from Thursday to Monday initially caused a 9% drop in BSE shares over fears that volumes on BSE would decline. Brokerage firm Nuvama previously highlighted that a Monday expiry would reduce industry volumes and impact retail traders’ options.
Jefferies on BSE Stock Performance
International brokerage firm Jefferies commented that SEBI's push to spread out F&O expiry days could ease concerns for BSE. The brokerage believes:
-
NSE might revert to Thursday expiries, while BSE continues with Tuesday.
-
This move reduces fears of BSE losing market share, which could have impacted BSE’s EPS by 12%.
-
Jefferies maintained a 'hold' rating on BSE shares, setting a target price of ₹5,250 per share, implying a 12% upside from current levels.
Market Outlook for BSE
With NSE’s deferral of expiry changes and SEBI’s regulatory clarity, BSE shares have recovered most of their recent losses. Analysts believe that lower regulatory risks, improved trading volumes, and better market conditions could support further re-rating of BSE stock.
Conclusion
BSE’s 17% rally highlights investor optimism after SEBI’s intervention. As expiry schedules stabilize and regulatory risks decline, BSE could maintain its competitive edge in the derivatives market. Traders and investors will closely watch SEBI's final decision on expiry days, which could further shape the future dynamics of Indian stock exchanges.
The Current active IPO are Aten Papers & Foam Limited, Infonative Solutions Limited,Spinaroo Commercial Limited,Retaggio Industries Limited,Identixweb Limited.
The Closed IPOs are ATC Energies System Limited, Shri Ahimsa Naturals Limited, Desco Infratech Limited
Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX.
Join our Trading with CA Abhay Telegram Channel for regular Stock Market Trading and Investment Calls by CA Abhay Varn - SEBI Registered Research Analyst.
Related News
Disclaimer
The information provided on this website is for educational and informational purposes only and should not be considered as financial advice, investment advice, or trading recommendations.
Trading in stocks, forex, commodities, cryptocurrencies, or any other financial instruments involves high risk and may not be suitable for all investors. Prices can fluctuate rapidly, and there is a possibility of losing part or all of your invested capital.
We do not guarantee any profits, returns, or outcomes from the use of our website, services, or tools. Past performance is not indicative of future results.You are solely responsible for your investment and trading decisions. Before making any financial commitment, it is strongly recommended to consult with a qualified financial advisor or do your own research.
By accessing or using this website, you acknowledge that you have read, understood, and agree to this disclaimer. The website owners, partners, or affiliates shall not be held liable for any direct or indirect loss or damage arising from the use of information, tools, or services provided here.